ADH1A · Western blot design guide

ADH1A Western Blot Planning Guide

Plan an ADH1A Western blot around the catalog-observed 39.9 kDa band, image-backed PB10029 evidence, HPA controls, and verified protocol records.

Evidence assembled July 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for ADH1A: expected band 39.9 kDa, antibody PB10029, and PMC-cited SDS-PAGE protocol steps
ADH1A Western blot protocol sheet — expected band 39.9 kDa, antibody PB10029, controls and PMC citations. Open the full ADH1A WB guide →

ADH1A Western Blot Experimental Design Guide

Expected bands, documented protocol parameters, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band 39.9 kDa
Observed band Not reported — verify product WB image
Gel 12-15%
Positive control ⓘ Liver
Negative control ⓘ Bone marrow
Important caveats
Reasons your observed band may differ from the expected size.
ⓘ Calculated mass 39.9 kDa
ⓘ Localization Cytoplasm
ⓘ Processing / PTM Record-dependent
ⓘ Reactivity Human / Mouse / Rat
Section 1

Real Curated ADH1A Western Blot Protocols

Start with the molecular-weight rule, then compare verified publication-derived conditions.

Recommended Western blot protocol parameters
Sample / lysateAppendix
Gel %12-15%
Load20-30 µg total protein per lane
TransferSemi-dry, standard transfer
Membrane0.45 µm PVDF
Blocking5% non-fat milk or 5% BSA in TBST
PrimaryPB10029 at datasheet starting dilution
Primary incubationOvernight at 4 °C with gentle agitation
SecondarySpecies-matched HRP conjugate at validated dilution
Wash3 × 5 min in TBST
DetectionChemiluminescent substrate
ExposureBracket exposures to avoid saturation
Section 2

What Is the Expected ADH1A Western Blot Band Size?

Use the product-observed 39.9 kDa band as the primary planning value and retain the UniProt calculated mass as context.

What am I looking at on my blot?
39.9 kDaMatches the authoritative product WB observation.
39.9 kDa calculatedUse as UniProt context, not as a replacement observed band.
Unexpected additional signalDo not assign identity without orthogonal positive/negative controls.
💡Expected ADH1A appearancePlan around 39.9 kDa and keep the calculated mass as supporting context.
How each factor affects band size
Catalog-observed band39.9 kDa; use this as the primary experimental expectation.
Calculated mass39.9 kDa from UniProt P07327; retain as context.
Gel selection12-15%; shared with the recommended protocol and poster.
Specificity checkCompare the lead HPA positive and negative controls with PB10029.
Why is my band missing or off?
SituationLikely causeNext action
39.9 kDaMatches the authoritative product WB observation.Confirm with orthogonal controls and the linked product record.
Additional bandMay reflect processing, modification, or non-specific signal.Run a dilution series and compare positive/negative controls.
Weak signalTarget abundance or transfer may be limiting.Verify transfer, increase positive-control abundance, and bracket exposure.

Sample controls for ADH1A Western blot

🧪Use Liver as the first positive-control candidate and Bone marrow as the HPA Not detected negative candidate.
Positive control: Liver (Medium)
Negative control: Bone marrow (Not detected)
HPA protein score determines control status; other expression data is supporting context only.

HPA tissue expression evidence for ADH1A

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Positive expression · recommended positive controls

TissueCell typeLevelEvidenceSource
Liver Reported tissue cells Medium Protein (HPA) HPA →
Small intestine Reported tissue cells Medium Protein (HPA) HPA →
Appendix Reported tissue cells Medium Protein (HPA) HPA →
Duodenum Reported tissue cells Medium Protein (HPA) HPA →

Undetected expression · recommended negative controls

TissueCell typeLevelEvidenceSource
Bone marrow Reported tissue cells Not detected Protein (HPA) HPA →
Bronchus Reported tissue cells Not detected Protein (HPA) HPA →
Section 3

Advanced ADH1A Western Blot Tips

Deeper troubleshooting and optimisation questions for ADH1A, answered from its protein features.

Which band should guide the blot?
Use 39.9 kDa, the observation attached to the authoritative PB10029 WB record.
How should calculated mass be interpreted?
Treat the UniProt calculated mass as context; it does not replace the catalog-observed 39.9 kDa expectation.
Which positive control should I start with?
Start with Liver, the lead HPA protein-expression candidate.
Which negative control is defensible?
Use Bone marrow as an orthogonal HPA Not detected candidate.
Which gel should I use?
Use 12-15% consistently across the quick facts, protocol table, and poster.
What transfer method to use for ADH1A Western blot?
Use the transfer method in the recommended protocol and verify transfer before blocking.
How should PB10029 be started?
Start at the linked datasheet condition and run a three-point primary-antibody dilution test.
Which publication-derived protocols can I compare?
No verified publication protocol was supplied; use only the deterministic recommended protocol.
Boster reagents

ADH1A Western Blot Reagents

Human/Mouse/Rat-reactive ADH1A Western blot reagents with authoritative product imagery.

Real WB data Western blot validation image for ADH1A using PB10029; observed band 39.9 kDa
Anti-Alcohol Dehydrogenase/ADH1A Antibody Picoband®
Cat # PB10029

Only image-backed, WB-validated Human/Mouse/Rat recommendations from the prepared catalog evidence are shown.

Source: prepared picoband-wb product evidence; each card retains its own SKU, URL, observed band, and authoritative WB image.

References

  1. UniProt P07327
  2. Human Protein Atlas — ADH1A
  3. PB10029 product record
  4. PMC11629119 — In Vitro Hepatic Metabolism Input Parameters Support Toxicokinetic Simulations for the Formation of Methoxy Propionic Acid From β-Isomer Propylene Glycol Methyl Ether (Pharmacology research & perspectives, 2024)
  5. PMC12475006 — Overexpression of alcohol dehydrogenase 1 A inhibits the progress of triple negative breast cancer via Wnt/β-catenin signaling (Scientific reports, 2025)
  6. PMC9169692 — Six Types of Tea Reduce Acute Alcoholism in Mice by Enhancing Ethanol Metabolism, Suppressing Oxidative Stress and Inflammation (Frontiers in nutrition, 2022)